动脉瘤性蛛网膜下腔出血后神经功能结局因社会经济阶层而异
回顾性分析2010至2015年在一所三级转诊大学医院(UH)和安全网县医院(CH)接受显微手术治疗的破裂颅内动脉瘤患者,UH组73例、CH组58例。校正疾病严重程度、住院时间和保险状态后,CH组患者出院时改良Rankin量表评分不良的风险是UH组的3.73倍(95%CI 1.25-12.14),格拉斯哥结局量表评分不良的风险是UH组的3.08倍(95%CI 1.04-9.61)。作者认为安全网医院系统资源有限可能是结局差异的主要驱动因素。
要点
- UH组从破裂到干预的时间短于CH组(P<0.001),入院时插管率高于CH组(P=0.01)。
- UH组临床血管痉挛使用维拉帕米更频繁,为每患者每日0.13次(95%CI 0.09-0.18),CH组为每患者每日0.077次(95%CI 0.047-0.12),但迟发性脑缺血无差异(P=0.15)。
- 校正后CH组出院时改良Rankin量表评分不良的风险是UH组的3.73倍(95%CI 1.25-12.14),格拉斯哥结局量表评分不良的风险是UH组的3.08倍(95%CI 1.04-9.61)。
核心结论
- 安全网医院系统资源有限可能是所识别的破裂脑动脉瘤人群医疗差异的主要驱动因素。
- 作者认为重新分配资源以补充高级住院急性护理技术、更重要的是补充急性期后护理环境,可以缩小结局差距。
研究设计与样本
- 回顾性综述2010至2015年在一所三级转诊大学医院(UH)和安全网县医院(CH)接受治疗的破裂颅内动脉瘤患者。
- 共识别UH患者73例和CH患者58例。
主要发现
- UH组从破裂到干预的时间短于CH组(P<0.001),入院时插管率高于CH组(P=0.01)。
- UH组临床血管痉挛使用维拉帕米为每患者每日0.13次(95%CI 0.09-0.18),CH组为每患者每日0.077次(95%CI 0.047-0.12),迟发性脑缺血无差异(P=0.15)。
- CH队列多数无保险(26.3%;UH 0%)或享有医疗补助(59.7%;UH 35.2%)(P<0.001)。
- UH出院至家庭或康复中心的比例高于CH(82% vs. 67.3%;P=0.04)。
- 校正疾病严重程度、住院时间和保险状态后,CH患者出院时改良Rankin量表评分不良的风险是UH患者的3.73倍(95%CI 1.25-12.14),格拉斯哥结局量表评分不良的风险是UH患者的3.08倍(95%CI 1.04-9.61)(P=0.02和P=0.04)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate potential health care discrepancies in patients with ruptured cerebral aneurysms undergoing microsurgical intervention. METHODS: We retrospectively reviewed patients with ruptured intracranial aneurysms treated at our tertiary referral university hospital (UH) and safety net county hospital (CH) from 2010 to 2015. We identified 73 UH patients and 58 CH patients. RESULTS: UH patients had shorter time duration between rupture and intervention (P < 0.001) and higher rates of intubation on admission (P = 0.01). Verapamil was more frequently used for clinical vasospasm in UH patients, at 0.13 (95% confidence interval [CI], 0.09-0.18) treatments per patient per day versus 0.077 (95% CI, 0.047-0.12) treatments per patient per day in CH patients, though there was no difference in delayed cerebral ischemia (P = 0.15). The majority of the CH cohort was uninsured (26.3%; UH 0%) or had Medicaid (59.7%; UH 35.2%) (P < 0.001). The UH had more dispositions to home or rehabilitation centers than the CH (82% vs. 67.3%; P = 0.04). After adjusting for disease severity, hospital stay, and insurance status, CH patients were 3.73 (95% CI, 1.25-12.14) times more likely to be discharged with a poor modified Rankin Scale score and 3.08 (95% CI, 1.04-9.61) times more likely to be discharged with a poor Glasgow Outcome Scale score compared with UH patients (P = 0.02 and P = 0.04, respectively). CONCLUSIONS: Limited resource availability in a safety net hospital system could be a major driving force behind the health care discrepancy identified in our ruptured cerebral aneurysm population. Reallocation of resources to supplement advanced inpatient acute care technologies and, more importantly, post-acute care environments can narrow the outcomes gap.
引用
- Strickland BA, Mert M, Ravina K, et al. Discrepancy in Neurologic Outcomes Following Aneurysmal Subarachnoid Hemorrhage as a Function of Socioeconomic Class. World Neurosurg. 2020. PMID: 32217180. doi:10.1016/j.wneu.2020.03.087
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。